SHERRIE LALANDE: Open Payments
NPI 1033413877 · BLAIRSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 14 payments from 10 companies in 2025. Trend: 2023 $526 · 2024 $221 · 2025 $533
Food & beverage: $434Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $197 |
| ABBVIE INC. | 2 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $37 |
| Caris MPI, Inc. | 1 | $27 |
| BeOne Medicines USA, Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Exelixis Inc. | 1 | $21 |
Products named: RYBREVANT, IMBRUVICA, NINLARO, TALVEY, EPKINLY, MI CANCER SEEK, BRUKINSA, Trodelvy.
Industry payments across GA — which companies pay providers there.
